Literature DB >> 26217456

Perfusion computed tomography in renal cell carcinoma.

Chandan J Das1, Usha Thingujam1, Ananya Panda1, Sanjay Sharma1, Arun Kumar Gupta1.   

Abstract

Various imaging modalities are available for the diagnosis, staging and response evaluation of patients with renal cell carcinoma (RCC). While contrast enhanced computed tomography (CT) is used as the standard of imaging for size, morphological evaluation and response assessment in RCC, a new functional imaging technique like perfusion CT (pCT), goes down to the molecular level and provides new perspectives in imaging of RCC. pCT depicts regional tumor perfusion and vascular permeability which are indirect parameters of tumor angiogenesis and thereby provides vital information regarding tumor microenvironment. Also response evaluation using pCT may predate the size criteria used in Response Evaluation Criteria in Solid Tumors, as changes in the perfusion occurs earlier following tissue kinase inhibitors before any actual change in size. This may potentially help in predicting prognosis, better selection of therapy and more accurate and better response evaluation in patients with RCC. This article describes the techniques and role of pCT in staging and response assessment in patients with RCCs.

Entities:  

Keywords:  Angiogenesis; Anti-angiogenic therapy; Perfusion computed tomography; Renal cell carcinoma

Year:  2015        PMID: 26217456      PMCID: PMC4506935          DOI: 10.4329/wjr.v7.i7.170

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  22 in total

Review 1.  Perfusion CT: a worthwhile enhancement?

Authors:  K A Miles; M R Griffiths
Journal:  Br J Radiol       Date:  2003-04       Impact factor: 3.039

Review 2.  Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review.

Authors:  K A Miles
Journal:  Eur J Radiol       Date:  1999-06       Impact factor: 3.528

3.  Antitumor effects of angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470) against murine renal cell carcinoma.

Authors:  T Fujioka; M Hasegawa; K Ogiu; Y Matsushita; M Sato; T Kubo
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

4.  Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment.

Authors:  Olga Maksimovic; Christina Schraml; Joerg T Hartmann; Michael Bitzer; Claus D Claussen; Jan Pintoffl; Marius Horger
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

5.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; Leena M Hamberg; Peter F Hahn; Christopher G Willett; Sanjay Saini; Peter R Mueller; Ting-Yim Lee
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

6.  Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.

Authors:  Caecilia S Reiner; Matthias Roessle; Thore Thiesler; Daniel Eberli; Ernst Klotz; Thomas Frauenfelder; Tullio Sulser; Holger Moch; Hatem Alkadhi
Journal:  Invest Radiol       Date:  2013-04       Impact factor: 6.016

7.  Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.

Authors:  Adeel Sabir; Rachel Schor-Bardach; Carol J Wilcox; Syed Rahmanuddin; Michael B Atkins; Jonathan B Kruskal; Sabina Signoretti; Vassilios D Raptopoulos; S Nahum Goldberg
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

8.  Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.

Authors:  Hersh Chandarana; Andrew B Rosenkrantz; Thais C Mussi; Sooah Kim; Afshan A Ahmad; Sean D Raj; John McMenamy; Jonathan Melamed; James S Babb; Berthold Kiefer; Atilla P Kiraly
Journal:  Radiology       Date:  2012-12       Impact factor: 11.105

9.  Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma.

Authors:  T Morita; N Shinohara; A Tokue
Journal:  Br J Urol       Date:  1994-10

10.  Study of 320-slice dynamic volume CT perfusion in different pathologic types of kidney tumor: preliminary results.

Authors:  Chao Chen; Qi Liu; Qiang Hao; Bing Xu; Chao Ma; Huojun Zhang; Qianjin Shen; Jianping Lu
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more
  6 in total

Review 1.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

Review 2.  Recent advances in imaging techniques of renal masses.

Authors:  Ankita Aggarwal; Chandan J Das; Sanjay Sharma
Journal:  World J Radiol       Date:  2022-06-28

3.  Relative Computed Tomography (CT) Enhancement Value for the Assessment of Microvascular Architecture in Renal Cell Carcinoma.

Authors:  Ai-Mei Ouyang; Zhao-Long Wei; Xin-You Su; Kun Li; Dong Zhao; De-Xin Yu; Xiang-Xing Ma
Journal:  Med Sci Monit       Date:  2017-07-31

4.  Is there a role for perfusion imaging in assessing treatment response following ablative therapy of small renal masses-A systematic review.

Authors:  S J Withey; J Gariani; K Reddy; D Prezzi; C Kelly-Morland; S Ilyas; A Adam; V Goh
Journal:  Eur J Radiol Open       Date:  2018-07-24

Review 5.  Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma.

Authors:  Rahul Jena; Tushar Aditya Narain; Uday Pratap Singh; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2021-04-01

6.  Comparison of Renal Blood Flow Using Maximum Slope-Based Computed Tomography Perfusion and Ultrasound Flow Probe in Healthy Dogs.

Authors:  Sang-Kwon Lee; Youjung Jang; Jin-Woo Jung; Hyejin Je; Jihye Choi
Journal:  Front Vet Sci       Date:  2020-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.